Browsing: advanced

Patients with an advanced form of lung cancer lived 56 percent longer without their disease progressing when radiotherapy was added…

A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting toxicities observed, and showed…

An immunotherapy-based regimen combining durvalumab and the PARP inhibitor, olaparib, demonstrated encouraging long-term survival outcomes for patients with advanced or…

Results from a clinical trial have revealed nearly one third (29.2 percent) of patients with advanced melanoma saw their tumors…